Immunotherapy, particularly immune checkpoint inhibitors (ICIs) such as anti-programmed cell death protein 1 (PD-1) and its ligand (PD-L1) drugs, has emerged as a novel and effective treatment strategy for GTN. Here, CD274 is linked to gestational trophoblastic neoplasm.